Screener
Aurinia Pharmaceuticals AUPH Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Unrealized loss on available-for-sale securities | (97) | (80) | (378) | (258) |
| Comprehensive income | $37,317 | $21,433 | $71,391 | $44,599 |
| Earnings per share | ||||
| Basic | $0.29 | $0.16 | $0.55 | $0.33 |
| Diluted | $0.28 | $0.16 | $0.53 | $0.32 |
| Shares used in computing earnings per share | ||||
| Basic | 130,081 | 134,873 | 131,221 | 136,878 |
| Diluted | 133,530 | 137,526 | 135,518 | 140,193 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's shares (diluted)?
- Aurinia Pharmaceuticals (AUPH) reported shares (diluted) of 133.5M in Q2 2026.
- How has Aurinia Pharmaceuticals's shares (diluted) changed year-over-year?
- Aurinia Pharmaceuticals's shares (diluted) decreased by 2.9% year-over-year, from 137.5M to 133.5M.
- What is the long-term trend for Aurinia Pharmaceuticals's shares (diluted)?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's shares (diluted) has grown at a 2.0% compound annual growth rate (CAGR), from 513.4M to 555.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Aurinia Pharmaceuticals's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude